Inadequate Myelination of Neurons Tied to Autism: Study
Inadequate Myelination of Neurons Tied to Autism: Study

Inadequate Myelination of Neurons Tied to Autism: Study

A mouse model of autism and postmortem brains of autistic individuals showed a lack of mature oligodendrocytes and less myelination than controls.

Lisa Winter
Lisa Winter

Lisa Winter became social media editor for The Scientist in 2017. In addition to her duties on social media platforms, she also pens obituaries for the website. She graduated from Arizona State University, where she studied genetics, cell, and developmental biology.

View full profile.

Learn about our editorial policies.

Feb 4, 2020


Insufficient myelination, likely caused by a lack of mature oligodendrocytes, is linked to autism spectrum disorder, according to a study in mice and postmortem human brains published yesterday (February 3) in Nature Neuroscience.

Myelin, the fatty substance that sheaths and insulates the axons of neurons, is responsible for aiding the quick delivery of signals throughout the brain. Too little myelin leaves the cells vulnerable to damage (as with multiple sclerosis), while too much can muddle the message. Oligodendrocytes (OL) are the cells that control myelination. Previous research has shown that myelin is typically thinner in those with autism spectrum disorder (ASD), while the current study explores the source of the problem.

While studying mouse brains for genetic mutations that cause Pitt-Hopkins syndrome, an autism-related genetic disorder, the team noticed irregular myelination and inconsistent expression of Tcf4, a gene that regulates OL activity. 

Turning their attention to human cadavers, the researchers found deficiencies in myelin sheathing in brains from people with autism compared to controls, echoing what was found in the mice. A genetic analysis revealed that the homologous gene, TCF4, also contained varied mutations in regulatory regions. There was a noticeable lack of mature OL in the ASD brains when compared to the controls and an overabundance of immature cells, and myelination was not happening sufficiently.

“This makes us think that the cells that are myelinating are doing it properly, it’s just that there are not a lot of them,” coauthor Joseph Bohlen told Spectrum when his then-unpublished findings were presented at the Society for Neuroscience meeting in Chicago in October.

Future research will focus on the creation of brain organoids with irregular myelination and testing compounds that could target OL and increase myelin production. The authors’ hope is that if children with autism receive early identification, a treatment could mitigate some of their symptoms.

Lisa Winter is the social media editor for The Scientist. Email her at or connect on Twitter @Lisa831.